# Antibiotika

## Klassen

| Class | Information |
| --- | --- |
| __Aminopenicillins__<br>Amoxicillin, Ampicillin, Piperacillin, Pivmecillinam | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative<br>_Respiratory Tract Infections, Endocarditis, Urinary Tract Infections_ |
| __Beta-Lactamase-Inhibitor__<br>Sulbactam, Clavulanic Acid, Tazobactam | __Mechanism of Action:__ Biding and Degradation of the beta-lactamase<br>__Bacteria:__ Gram-Negative<br>_Staphylococcus (MRSA), Enterobacteriaceae (Klebsiella pneumoniae, Citrobacter, Proteus vulgaris, Morganella, Salmonella, Shigella, Escherichia coli), Haemophilus influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Mycobacterium tuberculosis_ |
| __Cephalosporins__<br>__First Generation:__<br> Cefazolin<br>__Second Generation:__ Cefuroxim<br>__Third Generation:__ Ceftriaxon, Cefotaxim  | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ ↓ Gram-Positive + ↑ Gram-Negative<br>__Second Generation:__ _Haemophilus influenzae, Enterobacter aerogenes and some Neisseria, and Klebsiella pneumoniae_<br>__Third Generation:__ _Hospital-Acquired Infections, Penetrate the Central Nervous System, Meningitis (caused by pneumococci, meningococci), H. influenzae, and susceptible E. coli, Klebsiella, and penicillin-resistant N. gonorrhoeae_
| __Carbapenems__<br>Ertapenem, Meropenem, Imipenem | __Mechanism of Action:__ Inhibiting bacterial cell wall synthesis<br>__Bacteria:__ ↓ Gram-Positive + ↑↑ Gram-Negative<br>___Commonly used for the treatment of Severe or High-Risk bacterial Infections__, Enterobacteriaceace (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Citrobacter freundii, Proteus mirabilis, and Serratia marcescens), E. coli, K. pneumoniae,Pseudomonas aeruginosa and Acinetobacter species_
| __Macrolides__<br>Erythromycin, Clarithromycin, Azithromycin, Roxithromycin, Fosfomycin | __Mechanism of Action:__ Inhibit protein synthesis in bacteria<br>__Bacteria:__ Gram-Positive + ↓↓ Gram-Negative<br>_Streptococcus pneumoniae, Mycoplasma, Chlamydia, and Legionella pneumophilia, Mycobacteria, Beta-hemolytic Bacteria (streptococci, pneumococci, staphylococci, and enterococci)_
| __Fluoroquinolones__<br>Ciprofloxacin, Moxifloxacin, Levofloxacin | __Mechanism of Action:__ Chemotherapeutic bactericidal drugs interfering with bacterial DNA replication<br>__Bacteria:__ Gram-Positive + Gram-Negative<br>_First line in serious acute cases of Pyelonephritis or bacterial Prostatitis, Hospital-Acquired Genitourinary Infections, Hospital-Acquired Pneumonia_ |
| __Aminoglycosides__<br>Gentamicin, Tobramycin, Amikacin | __Mechanism of Action:__ Inhibition of protein synthesis<br>__Bacteria:__ Gram-Negative (↑↑ Aerobes, ↓↓↓↓ Anaerobes)<br>_Sepsis, Complicated Intra-Abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Respiratory Tract Infections_ |
| __Tetracyclines__<br>Doxycyclin | __Mechanism of Action:__ Inhibiting protein synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative, Exceptions include Pseudomonas aeruginosa and Proteus spp.<br>_Acne, Cholera, Brucellosis, Plague, Malaria, and Syphilis_ |
| __Nitroimidazole__<br>Metronidazol, Tinidazole | __Mechanism of Action:__  Inhibiting nucleic acid synthesis<br>__Bacteria:__ Gram-Positive + Gram-Negative, Exceptions include Pseudomonas aeruginosa and Proteus spp.<br>_Acne, Cholera, Brucellosis, Plague, Malaria, and Syphilis_ |
| __Glycopeptides__<br>Vancomycin | – |
| __Antimycobacterial Agents__<br>Rimfapicin | __Mechanism of Action:__ Inhibiting bacterial DNA-dependent RNA synthesis

## Anpassung bei Niereninsuffizienz

| Name | Typ | Anpassung |
| --- | --- | --- |
| Amikacin | ... | ... |
| Amoxicillin | p.o. | ... |
| Amoxicillin/Clavulansäure<br>Amoxiclav, Amoxicomp | p.o. | ... |
| Ampicillin/Sulbactam<br>Unacid | i.v. | GFR ≥30: 3000 mg/6-8h<br>GFR 15≤30: 3000 mg/12h<br>GFR 5≤15: 3000 mg/24h<br>GFR <5: 3000 mg/48h<br>Dialyse: init. 3000 mg; 1500-3000 mg/24h |
| Azithromycin | ... | ... |
| Cefazolin | ... | ... |
| Cefotaxim | i.v. | GFR >10: 2000 mg/8h<br>GFR 5-10: init. 2000 mg; 1000 mg/8h<br>GFR < 5: init. 2000 mg; 500 mg/12h<br>Dialyse: init. 2000-3000 mg; 1000-1500 mg/12h<br>CVVH: 2000 mg/6-12h |
| Ceftriaxon | i.v. | GFR >10: 2000 mg/12-24h<br>GFR ≤10: 2000 mg/24h<br>Dialyse: 2000 mg/24h<br>CVVH: 2000 mg/12-24h |
| Cefuroxim | i.v. | GFR ≥20: 1500 mg/8h<br>GFR 10≤20: 750 mg/12h<br>GFR <10: 750 mg/24h<br>Dialyse: init. 1500 mg; 750 mg/24h<br>CVVH: 750-1500 mg/12h |
| Ciprofloxacin | i.v. | GFR 30-60: 400 mg/12h<br>GFR <30: 400 mg/24h<br>Dialyse: 400 mg/24h<br>Dialyse und normale hepatische Funktion: 400 mg/12h<br>CVVH: 400 mg/8-12h |
| Ciprofloxacin | p.o. | GFR 30-60: 500 mg/12h<br>GFR <30: 500 mg/24h<br>Dialyse: 500 mg/24h<br>Dialyse und normale hepatische Funktion: 500 mg/12h |
| Clarithromycin | ... | ... |
| Doxycyclin | ... | ... |
| Ertapenem | ... | ... |
| Erythromycin | ... | ... |
| Flucloxacillin<br>Floxacillin | ... | ... |
| Fosfomycin | p.o. | GFR >20: 3000 mg<br>GFR <20: kontraindiziert |
| Gentamicin | ... | ... |
| Imipenem | ... | ... |
| Levofloxacin | alle | GFR >50: 500 mg/12-24h<br>GFR 20-50: init. 500 mg; 250 mg/12-24h<br>GFR 10-19: init. 500 mg; 125 mg/12-24h<br>GFR <10: init. 500 mg; 125 mg/24h<br>Dialyse: init. 500-750 mg; 250 mg/24h<br>CVVH: init. 500-750 mg; 500-750 mg/24h |
| Metronidazol<br>Clont | ... | ... |
| Meropenem | ... | ... |
| Moxifloxacin | ... | ... |
| Nitrofurantoin | p.o. | GFR >60: 100 mg/8-12h<br>GFR <45: kontraindiziert |
| Piperacillin/Tazobactam<br>Tazobac | i.v. | GFR ≥40: 4500 mg/6h<br>GFR 20≤40: 4500/8h<br>GFR <20: 4500 mg/12h<br>Dialyse: 4500 mg/12h; nach der Dialyse zusätzlich 2250 mg<br>CVVH: 4500 mg/8-12h |
| Pivmecillinam | p.o. | ... |
| Roxithromycin | ... | ... |
| Tobramycin | ... | ... |
| Tinidazole | ... | ... |
| Vancomycin | ... | ... |
| Rimfapicin | ... | ... |
